Transforming growth factor β (TGF-β) is critical for embryonic development, adult tissue homeostasis, and tumor progression. TGF-β suppresses tumors at early stage, but promotes metastasis at later stage through oncogenes such as Twist1. Gamma-synuclein (SNCG) is overexpressed in a variety of invasive and metastatic cancer. Here, we show that TGF-β induces SNCG expression by Smad-Twist1 axis, thus promoting TGF-β- and Twist1-induced cancer cell migration and invasion. We identify multiple Twist1-binding sites (E-boxes) in SNCG promoter. Chromatin immunoprecipitation and luciferase assays confirm the binding of Twist1 to the E-boxes of SNCG promoter sequence (-129/-1026 bp). Importantly, the Twist1-binding site close to the transcription initiation site is critical for the upregulation of SNCG expression by TGF-β and Twist1. Mutations of Twist1 motif on the SNCG promoter constructs markedly reduces the promoter activity. We further show that TGF-β induces Twist1 expression through Smad thereby enhancing the binding of Twist1 to SNCG promoter, upregulating SNCG promoter activity and increasing SNCG expression. SNCG knockdown abrogates TGF-β- or Twist1-induced cancer cell migration and invasion. Finally, SNCG knockdown inhibits the promotion of cancer metastasis by Twist1. Together, our data demonstrate that SNCG is a novel target of TGF-β-Smad-Twist1 axis and a mediator of Twist1-induced cancer metastasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967338PMC
http://dx.doi.org/10.1038/s41419-018-0657-zDOI Listing

Publication Analysis

Top Keywords

sncg promoter
20
cancer cell
12
cell migration
12
migration invasion
12
sncg
12
sncg expression
12
twist1-induced cancer
12
twist1
8
tgf-β induces
8
tgf-β- twist1-induced
8

Similar Publications

Article Synopsis
  • Adeno-associated virus (AAV) can effectively deliver genes to retinal ganglion cells (RGCs), but there's a limitation due to packaging size and cell selectivity of the therapeutic genes.
  • This study evaluates the effectiveness of various RGC-selective promoters, including gamma-synuclein (SNCG) and neurofilament heavy chain (NEFH), alongside parts of the atonal bHLH transcription factor 7 (ATOH7) enhancer.
  • Results indicate that both SNCG and NEFH promoters are similarly effective for gene delivery and enhancing RGC survival, but the NEFH promoter has the advantage of a smaller size for packaging, making it more suitable for delivering larger genes in future applications.
View Article and Find Full Text PDF

Genome-Wide Methylation Profiling in the Thalamus of Scrapie Sheep.

Front Vet Sci

February 2022

Laboratorio de Genética Bioquímica (LAGENBIO), Facultad de Veterinaria, Universidad de Zaragoza-IA2, IIS, Zaragoza, Spain.

Article Synopsis
  • * A study using whole-genome bisulfite sequencing (WGBS) found 8,907 differentially methylated regions (DMRs) in sheep infected with scrapie compared to healthy controls, indicating changes in DNA methylation patterns.
  • * Analysis reveals that these methylation changes affect genes related to cell functions and are linked to differential gene expression, suggesting that DNA methylation may play a regulatory role in prion-related brain disorders.
View Article and Find Full Text PDF

SIRT1 prevents retinal ganglion cell (RGC) loss in models of optic neuropathy following pharmacologic activation or genetic overexpression. The exact mechanism of loss is not known, prior evidence suggests this is through oxidative stress to either neighboring cells or RGC specifically. We investigated the neuroprotective potential of RGC-selective SIRT1 gene therapy in the optic nerve crush (ONC) model.

View Article and Find Full Text PDF

Optic neuropathies are a group of optic nerve (ON) diseases caused by various insults including glaucoma, inflammation, ischemia, trauma, and genetic deficits, which are characterized by retinal ganglion cell (RGC) death and ON degeneration. An increasing number of genes involved in RGC intrinsic signaling have been found to be promising neural repair targets that can potentially be modulated directly by gene therapy, if we can achieve RGC specific gene targeting. To address this challenge, we first used adeno-associated virus (AAV)-mediated gene transfer to perform a low-throughput screening in both male and female mouse eyes and identified the mouse γ-synuclein (mSncg) promoter, which specifically and potently sustained transgene expression in mouse RGCs and also works in human RGCs.

View Article and Find Full Text PDF

Restoration of normal DNA promoter methylation and expression states of cancer‑related genes may be an option for the prevention as well as the treatment of several types of cancer. Constitutional promoter methylation of BRCA1 DNA repair associated (BRCA1) gene is linked with a high risk of developing breast and ovarian cancer. Furthermore, hypomethylation of the proto‑oncogene γ synuclein (SNCG) is associated with the metastasis of breast and ovarian cancer and reduced disease‑free survival (DFS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!